Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues
Patent
1997-02-12
1999-11-30
Burke, Julie
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
530300, 514 12, 435 691, C07K 412, C07K 1447
Patent
active
059945044
ABSTRACT:
The invention relates to the discovery and purification of novel vitamin D response element binding proteins and the isolation of polynucleotide sequences encoding the proteins. Vitamin D response element binding proteins are distinct from the vitamin D receptor. Vitamin D response element binding proteins can interfere with the biological activity of the vitamin D receptor and other related intracellular receptor proteins. One aspect of the invention is to provide purified vitamin D response element binding proteins. Another aspect of the invention is to provide polynucleotides encoding the vitamin D response element binding proteins of the invention and to provide polynucleotides complementary to polynucleotide coding strand. Another aspect of the invention is to provide antibodies capable of binding to the vitamin D response element binding proteins of the invention. Another aspect of the invention is to provide assays for the detection or screening of therapeutic compounds that interfere with the interaction between vitamin D response element binding protein and vitamin D response elements.
REFERENCES:
patent: 4816567 (1989-03-01), Cabilly et al.
patent: 5064770 (1991-11-01), DeLuca et al.
Adelman et al., "In vitro deletional mutagenesis for bacterial production of the 20,000-Dalton form of human pituitary growth hormone," DNA 2:183-193 (1983).
Arbelle et al., "Inhibition of vitamin D receptor-retinoid X receptor-vitamin D response element complex formation by nuclear extracts of vitamin D-resistant new world primate cells," Endocrinology 137:786-789 (1996).
Ausubel et al., Current Protocols in Molecular Biology John Wiley & Sons vol. 1 (1995) pp. 1 & 2.
Brandon et al., "Glucocorticoid resistance in humans and nonhuman primates," Cancer Res. 49:2203-2213 (1989).
Chrousos et al., "Uterine estrogen and progesterone receptors in an estrogen- and progesterone- "resistant" primate," J. Clin. Endocrinol. Metab. 58:516-520 (1984).
Chrousos et al., "Adaptation of the mineralocorticoid target tissues to the high circulating cortisol and progesterone plasma levels in the sqirrel monkey," Endocrinol. 115:25-32 (1984).
Crea et al., "Chemical synthesis of genes for human insulin," Proc. Natl. Acad. Sci. USA 75:5765-5769 (1978).
Cunningham and Wells, "High-resolution epitope mapping of hGH-receptor interactions by alanine-scanning mutagenesis," Science 224:1081-1085 (1989).
Gacad and Adams, "Identification of a competitive binding component in vitamin D-resistant new world primate cells with a low affinity but high capacity for 1,25-dihydroxyvitamin D.sub.3 " J. Bone Min. Res. 8:27-35 (1993).
Goding et al., Monoclonal Antibodies: Principles and Practice pp. 59-103 Academic Press, Inc., San Diego (1986).
Goeddel et al., Gene Expression Technology: Methods in Enzymology vol. 185 Academic Press, Inc., San Diego (1991) pp. 1 & 2.
Houghten et al., "Generation and use of synthetic peptide combinatorial libraries for basic research and drug discovery" Nature 354:84-86 (1991).
Kaplit and Lowrey, iral Vector Gene Therapy and Neuroscience Applications, Academic Press, San Diego (1995) (pp. V-XVII).
Lam et al., "A new type of synthetic peptide library for identifying ligand-binding activity" Nature 354:82-84 (1991).
Lipsett et al., "The defective glucocorticoid receptor in man and nonhuman primates," Recent Prog. Hormone Res. 41:199-246 (1985).
Ozono et al., "The vitamin D-responsive element in the human osteocalcin gene" J. Biol. Chem. 265:21881-21888 (1990).
Roth ed. Protein Expression in Animal Cells, Academic Press, San Diego vol. 43 (1994) pp. 1 & 2.
Sambrook et al., Molecular Cloning: A Laboratory Manual 2nd edition, Cold Spring Harbor Press (1989) pp. 1 & 2.
Songyang et al., "SH2 domains recognize specific phosphopeptide sequences" Cell 72:767-778 (1993).
Takahashi et al.., "The mechanism of end-organ resistance to 1.alpha., 25-dihydroxycholecalciferol in the common marmoset" Biochem S. 227:555-563 (1985).
Veira et al., "Production of single-stranded plasmid DNA," Meth. Enzymol. 153:3-11 (1987).
Zoller and Smith, "Oligonucleotide-directed mutagenesis using M13-derived vectors: an efficient and general procedure for the production of point mutations in any fragment of DNA," Nucleic Acids Res. 10:6487-6500 (1982).
Arbelle et al Clin Research vol. 41 (2) Abstract 238A, 1993.
Haussler et al Bone vol. 17(2) Supplement 335-385, Aug. 1995.
Arbelle et al Endocrinology vol. 137(2) 786-788, 1996.
Burke Julie
Cedars-Sinai Medical Center
LandOfFree
Vitamin D response element binding protein does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vitamin D response element binding protein, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vitamin D response element binding protein will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1674108